1. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry Levothyroxine Sodium Tablets—In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing. Rockville, MD: February 2001.
2. Citizen's Petition. Jones Pharma, Inc. March 28, 2003.
3. Citizen's Petition. Abbott Laboratories. August 25, 2003.
4. Blakesley V, Awni W, Locke C, Ludden T, Granneman GR, Braverman LE. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable?Thyroid. 2004;14:191–200.
5. Food and Drug Administration. FDA Advisory Committee for Pharmaceutical Science.Briefing Document From Abbott Laboratories. Rockville, MD; May 12–13, 2003. Available at: http://www.fda.gov/ ohrms/dockets/ac/03/briefing/3926B1_02_A-Abbott%20.htm. Accessed March 23, 2005.